Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

MLA

Annick Ruffault, et al. “Stable Prevalence of Genotypic Drug Resistance Mutations but Increase in Non-B Virus among Patients with Primary HIV-1 Infection in France.” AIDS, vol. 17, Dec. 2003, pp. 2635–43. EBSCOhost, https://doi.org/10.1097/00002030-200312050-00011.

APA

Annick Ruffault, Jacques Izopet, Françoise Brun-Vézinet, Marie-Laure Chaix, Bernard Masquelier, Catherine Tamalet, Isabelle Pellegrin, Christiane Deveau, Martine Harzic, Laurence Meyer, Diane Descamps, Dominique Costagliola, Véronique Schneider, & Christine Rouzioux. (2003). Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS, 17, 2635–2643. https://doi.org/10.1097/00002030-200312050-00011

Chicago

Annick Ruffault, Jacques Izopet, Françoise Brun-Vézinet, Marie-Laure Chaix, Bernard Masquelier, Catherine Tamalet, Isabelle Pellegrin, et al. 2003. “Stable Prevalence of Genotypic Drug Resistance Mutations but Increase in Non-B Virus among Patients with Primary HIV-1 Infection in France.” AIDS 17 (December): 2635–43. doi:10.1097/00002030-200312050-00011.